[Weight reduction in obese diabetics: a double-blind study of diethylpropionate (author's transl)]
- PMID: 380178
[Weight reduction in obese diabetics: a double-blind study of diethylpropionate (author's transl)]
Abstract
In a double-blind study 40 overweight maturity-onset diabetics on a weight-reducing diet were randomly assigned to treatment with either the appetite-suppressant diethylpropion hydrochloride (Tenuate), or placebo. After treatment for 8 weeks the mean weight loss achieved by each group was 4.9 and 3.3%, respectively. This approximately equal weight loss was too slight to exert any significant effect on glucose tolerance. Thus, an additional effect of this anorexiant in comparison with diet restriction alone, as described in obese non-diabetic subjects, is not evident in the case of obese diabetic patients.
Similar articles
-
Double blind evaluation of long acting diethylpropion hydrochloride in obese patients from a general practice.Med J Aust. 1975 Jan 4;1(1):13-5. Med J Aust. 1975. PMID: 1092973 Clinical Trial.
-
Controlled-release diethylpropion hydrochloride used in a program for weight reduction.Clin Ther. 1981;3(5):329-35. Clin Ther. 1981. PMID: 7471128
-
An evaluation of behavioral techniques reinforced with an anorectic drug in a double-blind weight loss study.J Clin Psychiatry. 1980 Jul;41(7):234-7. J Clin Psychiatry. 1980. PMID: 6993445 Clinical Trial.
-
A double-blind controlled study of the use of diethylpropion hydrochloride (Tenuate) in obese patients in a rural practice.N Z Med J. 1978 Oct 25;88(622):321-2. N Z Med J. 1978. PMID: 282482 Clinical Trial.
-
New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.Diabetes Metab. 2002 Dec;28(6 Pt 1):437-45. Diabetes Metab. 2002. PMID: 12522323 Review.
Cited by
-
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD004096. doi: 10.1002/14651858.CD004096.pub2. Cochrane Database Syst Rev. 2005. PMID: 15674929 Free PMC article.